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Summary The objective of this review is to present and discuss the quality of life
(QOL) construct, more specifically the QOL in the field of health and disease also
designated as health-related quality of life (HRQOL). QOL is an everyday language
concept with a relatively short history in the health field. It became a principal end-
point in health care as a consequence of the development of patients’ rights
movements. It is important for clinical, economic and political decisions. There is no
gold standard way to measure QOL and the existence of a huge number of measures
and related QOL concepts makes it difficult to discuss QOL. This means that many
times we are using the same expression ‘‘QOL’’ but we are not talking about the same
thing. So we submit that it is important to keep looking for the good construct and the
good measure. The reason why we decide to evaluate QOL influences the measures
we choose. In general, QOL measures are based on questionnaires that must be short
and easy to answer. The interest in these kind of soft measures (in opposition to the
traditional hard physiologically or biochemically oriented measures) is growing fast.






Quality of life (QOL) is a popular concept used in
everyday language: In advertisements about do-
mestic appliances, cars, holidays, in politics, and so
on. People talk about QOL when addressing emo-
tional feelings, personal relationships, or profes-
sional events.
Efforts to measure QOL began with the report
from President Eisenhower’s Commission on Na-
tional Goals, intended to develop the QOL of the
American People. The report, published in 1960,
included a variety of social and environmental
factors such as, education, concern for the indivi-
dual, economic growth, health and welfare, and
the defence of free world. In 1964, the American
President Lyndon Johnston declared that ‘‘y goals
cannot be measured by the size of our bank
balance. They can only be measured by the quality
of the lives our people leady’’.1
In one of the first large studies in this field2
entitled, Quality of Life of American People, the
authors wrote that ‘‘the relationships between
objective conditions and psychological states is
very imperfect and that in order to know the
quality of life experience it will be necessary to go
directly to the individual himself for his description
of how his life feels to him’’. In their study, they
focused on ‘‘the experience of life rather than the
conditions of life’’.
QOL becomes a very important subject in social
sciences, from sociology to economy, from political
science to psychology. Some landmarks can be
considered in the history of QOL. Recently, Sen3
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(Nobel prize of economy in the late 1990s)
published a book named ‘‘Quality of Life’’. The
first studies2,4 focus primarily on the individual’s
perceptions of well-being rather than objective
indicators, emphasising general or global measures
of well-being. Liu’s5 study concludes that QOL
includes two components: the subjective one (or
psychological) and the objective one (or social,
economic, political and environmental). The sub-
jective component is more qualitative in nature,
and generally depends on the individual and is not
measurable, while objective components are more
quantitative, and likely to be measurable.
Evolution of health and QOL concepts
We went through a period in the mid-1960s during
which the validity of a patient rating a generic
health concept was questioned when it did not
agree with what was in the record or with what the
health provider said. The logic of validity has since
been turned around. We are now entering an era in
which the same findings are accepted as evidence
due to the need to include patient assessments as
part of the evaluation process, explains Ware.6
Historically, health concepts changed during the
second half of the 20th-century. Large studies
helped to change the importance of positive (or
healthy) perspectives on health. From the negative
health measures like the ‘‘five D’s’’ F death,
disease, disability, discomfort, and dissatisfaction
Fresearch on health has shifted towards the
assessment of more positive dimensions. The new
wave of health concepts developed new and more
positive health measures with the purpose of
evaluating health and not disease. These new
health measures influenced the QOL measures.
The large Alameda County Study7, defined
physical health in terms of energy levels, symp-
toms, chronic conditions, impairments, disability,
and general health perception. The Health Insur-
ance Experiment or the RAND Health Insurance
Study (HIE or HIS) defined four major health status
dimensions:8 physical health, mental health, social
health, and general health perceptions. The Med-
ical Outcomes Study (MOS) (a study of variations in
physicians’ practice styles and their impact on
patient’s outcomes) adopts five categories of
indicators of physical and mental health:9 clinical
status, physical functioning and well-being, mental
functioning and well-being, social/role functioning
and well-being, and general health perceptions.
These kinds of studies express and impact ideology
about health and disease concepts with impact on
QOL field and QOL evaluations.
The medical model changes towards a more
patient-centred medicine. Laine and Davidoff10
define patient-centred care as health care that is
closely congruent with and responsive to patients’
wants, needs, and preferences. This movement is
one component of the 1960s patients’ rights
movement. It is opposite to the provider-centred
model of care. The consequences of that move-
ment are the inclusion of more ‘‘soft’’ outcomes in
parallel with the traditional ‘‘hard’’ outcomes. QOL
is one of the innovative ‘‘softer’’ outcomes.
QOL is a primary end-point
Some authors11 define the importance of primary
end-points in clinical intervention explaining that
‘‘ideally, clinicians making treatment decisions
should refer to methodologically strong clinical
trials examining the impact of therapy on clinically
important outcomes. By clinically important out-
comes we mean outcomes that are important to
patients: health related quality of life, morbid end-
points such as stroke or myocardial infarction, or
death’’. Other scientists defend health-related
quality of life (HRQOL) measures must be included
in clinical trials as secondary end-points.12
Scanlon13 defends that QOL suffers from an
embarrassing richness of possibilities. What kind
of circumstances provide good conditions under
which to live? What kind of conditions make life
good according to oneself? What makes a life
valuable from the point of view of the universe?
Each of these questions admits different interpre-
tations and different answers. Each of these
questions can be asked from different points of
view (the subject, a benevolent third party like a
friend or parent, a conscientious administrator or
politician).
Is it necessary to have a QOL definition?
Defining QOL is important because the definition we
choose influences the evaluation technique we
adopt. Both are influenced by philosophic perspec-
tives, values and principles that influence the
research design. In fact, many articles addressing
QOL do not define the concept.14 Gill and Fein-
stein15 examining 75 randomly chosen articles using
QOL instruments found that very few had at-
tempted to define what their study meant by QOL
and to justify the QOL measure they used.
Hunt16 explains the lack of conceptual clarity
through two tendencies. The first one states that
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there is a general agreement on the components
and definition of QOL. In fact there is a wide
disagreement about the meaning of the term
‘‘quality of life’’ and how to measure it. Different
researchers or professionals prefer definitions and
measures influenced by the preoccupations of their
respective disciplines.
The second attitude is opposite to the first one
and defends that there is no gold standard for QOL
and, therefore, any one has the liberty to measure
‘‘quality of life’’ in any way whatsoever.
Philosophy of QOL evaluation
‘‘Quality of life’’ or rather the ‘‘good quality of
human life’’ can be discussed in various settings
(medical, social sciences, philosophy, etc.). Differ-
ent settings adopt the term QOL for different
purposes, each of them using different kinds of
assessment.
According to Hayry,17 there are three different
philosophies behind QOL assessment. One based on
sanctity of life, one on scientific efficiency, and
another on respect for human autonomy. The first
model assumes that human life is sacred, the
measurement of QOL unethical and not important
or secondary for clinical decisions. Prolonged life is
always the primary outcome without considerations
for QOL. The second model, views the evaluation of
life quality on scientific grounds and is preferred by
the economists, because it addresses aspects that
emphasise the efficiency and equity of the system
and facilitates decisions concerning resource allo-
cation. As scientific it stresses the objectivity of the
measures, mainly the reproducibility and measur-
ability by external observation. The third one,
respect for autonomy, stresses the viewpoint of
personal self-determination. It assumes that QOL is
no more and no less than what the person considers
it to be. This last model is proposed by many
interest groups, like the clergy, economists, politi-
cians, medical professionals and even the pharma-
ceutical industry.
In another analysis, Brock18 points out that
philosophy distinguishes three broad kinds of
theories that explain what is good for the individual
or what is a good life. The three alternative
theories of a good life are: hedonists, preference
satisfaction, and idealist theories.
The hedonists consider as the ultimate good for
people to be undergoing particular kinds of
conscious experiences that can be characterised
as pleasure, happiness, satisfaction, or enjoyment
that typically accompany the successful pursuits of
our desire. Preference satisfaction theories defend
that a good life consists in the satisfaction of
people’s desires or preferences. The idealist
theories defend that a good life consists of the
realisation of specific, explicit normative ideals.
QOL definition
QOL is recognised as a vague and ethereal entity,
something that many people talk about, but which
nobody knows very clearly what to do about . We
can find many definitions. According to Farquhar,19
QOL definitions can be classified as: global defini-
tions, component definitions (research-specific and
non-research-specific), focused definitions (explicit
or implicit), combination definitions and lay defini-
tions. As an example we chose some different
definitions:
QOL is a state of complete physical, mental, and
social well-being and not merely the absence of
disease or infirmity.20 QOL is the subjective
perception of satisfaction or happiness with life in
domains of importance to the individual.21 QOL is a
person’s sense of well-being that stems from
satisfaction or dissatisfaction with the areas of life
that are important to him/her.22 QOL is the
difference between a person’s expectations and
actual experience.23 QOL is an individual’s percep-
tion of their position in life in the context of the
culture and value system in which they live and in
relation to their goals, expectations, standards,
and concerns.24
The previous definitions include concepts such as
well-being, satisfaction, happiness, expectancy, or
functionality. We can find all these concepts in the
techniques used to measure QOL. No single defini-
tion of QOL, which is appropriate for both practice
and research, has become standard.
Are health and QOL the same thing?
For some researchers the answer is yes, for others
no. Guyatt et al.25 and Fries and Spitz26 explain
that health status, functional status, QOL, and
patient outcome, are concepts used interchange-
ably to refer the same idea of health. The concept
or idea of health varies from extreme to extreme,
from death to happiness. Because the concept of
health or QOL also depends on the level of income,
poor environment, lack of freedom, and because
these aspects are not important in medical con-
texts or for the evaluation of disease progress, we
can adopt a concept of HRQOL which will focus
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primarily on medical aspects. Physiological mea-
sures are important to clinicians but they mean
nothing to the patients. Often physiological mea-
sures are poorly related with well-being and
functional capacities. Patients with the same stage
of disease vary widely in the way they feel.
Wilson and Cleary27 used the terms health status
and HRQOL interchangeably (although recognising
that ‘‘the concept of QOL is distinct from health,
though related to it’’) Ware6 defends that QOL is a
much broader concept than health status, and
includes the latter. Fries and Spitz26 explain that
health status is a measure of QOL at a particular
point in time.
Revicki et al.28 describe that although functional
status, perceived or subjective health status, QOL,
and HRQOL are often used interchangeably, these
terms have subtle but important differences with
respect to dimensionality, perspective and scope.
QOL has meaning beyond an individual’s health.
The World Health Organization defines health as
a state of physical, social and mental well-being
and not merely the absence of disease or infirmity,
explaining that health is a resource for everyday
life, not the object of living. It is a positive concept
emphasising social and personal resources as well
as physical capabilities,29 meaning that health is a
basic resource for a good life or a good QOL.
General QOL is not the same as HRQOL
As we mentioned before, many people talk about
functional status and well-being as if they were
synonymous with QOL; however, it is recognised
that QOL is a much broader concept. For example,
Campbel et al.2 in a study designed to monitor the
QOL of American life with a national sample
identified 12 domains of life: community, educa-
tion, family life, friendships, health, housing,
marriage, nation, neighbourhood, self, standard
of living, and work. Flanagan30 in a study which
began in 1972, designed to identify the major
factors affecting the QOL of adult Americans, used
a different method he entitled ‘‘critical incident
technique’’ and identified 15 domains: material
comforts; health and personal safety; relationships
with relatives; having and rearing children; close
relationships with spouse or sexual partner; close
friends; helping and encouraging others; partici-
pating in government and local affairs; learning,
attending school, improving understanding; under-
standing yourself and knowing your assets and
limitations; work that is interesting, rewarding,
worthwhile; expressing yourself in a creative
manner; socialising with others; reading, listening
to music, or watching sports, other entertainment;
participation in active recreation.
In both studies, health is only one of the domains
of general QOL and emerged as the most important
one. We can study the QOL in each of the fields
described above, for example marriage-related
QOL, or work-related QOL. In our setting, we are
interested in HRQOL.
QOL in the field of disease
QOL related with (that depends on) disease or
HRQOL, can be defined as ‘‘the subjective assess-
ment of the impact of disease and treatment across
the physical, psychological, social and somatic
domains of functioning and well-being’’.28
HRQOL is a welcome addition or supplement to
the traditional physiological or biological measures,
because it describes and characterises what the
patient has experienced as the result of medical
care.
It is an important end-point because the litera-
ture strongly suggests that there is not a direct one-
to-one relationship between severity of abnormal-
ities, symptoms, functional limitations, disability
and loss of QOL.27 Health perceptions, well-being,
life satisfaction are not directly proportional to
symptoms and functional limitations, which in turn
are not directly proportional to physiological and
anatomic abnormalities. The effects flowing from
biological abnormalities to QOL are mediated and
modified by psychological, social and cultural
factors.31
QOL levels
According to Spilker,32 QOL must be viewed on a
number of levels. The author presents the different
levels as a pyramid in which the top consists of a
very general level, the middle a group of domains,
and the lower level all the aspects of each domain.
The assessment at a general QOL level can be a
question such as: ‘‘How would you rate your overall
quality of life during past week?’’ It can be
answered by everyone either healthy or sick, and
the results compared.
The second level must include different domains,
physical, psychological or social domains. It can be
applied to everyone, like the SF-36 or the WHO-
QOL-Bref both widely used measures of general




The third or more specific level can include the
domains of the second level as well as specific
characteristics of the disease. The QLQ-C30, a
measure developed by The European Organisation
for Research and Treatment of Cancer (EORTC)
includes scales (a group of items that measure
the same construct) and items-dimensions (items
expressing disease symptoms).
QOL models
We can find many models with which to explain
QOL, here are a few examples:
Hyland,33 refers that HRQOL used to be pre-
sented in two different approaches: One which he
calls ‘‘the multifaceted approach’’ consists of an
aggregation of several, conventionally agreed,
health indices. Another approach, ‘‘the causal
process approach’’ describes HRQOL as a causal
sequence resulting from an interaction between
morbidity and psychological factors. Hyland states
that the conventional approach in medicine is the
multifaceted approach. QOL is commonly consid-
ered as an outcome measure that is independent of
mortality and morbidity data,33 i.e. QOL and
morbidity are analysed as unrelated dependent
variables. In opposition to that traditional position,
Hyland proposes the causal sequence approach
which assumes that QOL must be affected by
morbidity, and therefore correlated with it. Since
QOL is also affected by psychological factors, QOL
measures must represent some kind of causal
interaction between morbidity and psychological
aspects.
Spilker32 proposes a model of how clinical
aspects influence patient QOL domains. It includes:
medical treatment (safety, efficacy and additional
measures), any adverse reactions due to treat-
ment, beneficial clinical effects and convenience
and costs. The above aspects are perceived or
filtered through patients’ values, beliefs and
judgements, and the net result of all the aspects
is the QOL.
Ormel et al.31 propose a model for understanding
how consequences of disease affect QOL. Symp-
toms and functional limitations place constraints on
an individual’s activities, endowments and re-
sources, thereby increasing their costs, and thus
reducing the behavioural means for achieving the
instrumental goals with subsequent negative ef-
fects on QOL.
Leventhal and Colman34 assume that the pa-
tients’ representations of a disease will affect the
salience, meaning and importance of the domains
involved in making QOL judgements. They propose
a process view model including the representation
of the disease threat, of the affective reactions
that serve both as motivators and inhibitors of
thoughts and actions, of the procedures of rules
of thought and action designed to more fully
define, control, cure and prevent a disease threat,
and of the contextual factors within the persons’
lives.
Wilson and Cleary27 propose a model that
includes five levels in the model: biological and
physiological variables, symptoms, functional sta-
tus, general health perceptions and overall QOL.
This diagram is mediated by the characteristics of
the individual (motivation, values, preferences)
and the characteristics of the environment (psy-
chological, social and economic support).
QOL measurement: composition,
domains, dimensions or factors
The multidimensionality of HRQOL measurement
considers various domains and various scores. The
number of domains should be determined either
empirically and/or theoretically. The number of
domains depend on the nature of the HRQOL
evaluation: whether we are using general QOL
instruments or disease-specific instruments.
Disease-specific instruments include items that
are symptoms of the disease (pain in arthritis) or
side effects of the treatment (nausea in cancer).
Measurements that include side effects or symp-
toms lead to the question of knowing if we are
measuring the QOL or what determines it. Some
scientists consider that they are separate, others
that it must be included in the measurements. The
ISPOR panel12 defends that collecting information
about symptoms or side effects is important for
clinical decisions but it is questionable if they
represent QOL.
Ware and Sherbourne35 described eight func-
tional domains of QOL: physical functioning, phy-
sical role, bodily pain, general health, vitality,
emotional role, mental health, social functioning.
Each domain is expressed by a score, and the total
result is expressed as a scattergram.
Ferran and Powers22 described four QOL satisfac-
tion dimensions. Each dimension as a score and the
sum of the dimension scores provide a total QOL
score.
The EORTC Group36 proposes a measure (QLQ-C30)
with 30 items, distributed by five functional scales,
one global health status scale, three symptom scales,
plus six item domains.
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Many other ways of measuring QOL can be found,
such as well-being measures, functional measures,
or symptom measures.
Properties of the QOL paradigm
Schipper et al.37 defend a number of operational
characteristics of the QOL paradigm: Multifactoriality,
self-administration, time variable, and subjectivity.
Multifactoriality means that the QOL parameter
includes more than a single aspect or domain. QOL
represents a broad range of human experiences
related to one’s overall well-being, and is influ-
enced by one’s perception of various personal
dimensions like physical, psychological, social,
economic, and political environment.28
Self-administration means that the person,
whose QOL we are trying to evaluate is the one
who knows best. Physicians and nurses tend to
focus on physiological measures. Psychologists,
social workers and family tend to focus more on
psychosocial measures. QOL ratings performed by
medical doctors, nurses, caregivers, and others are
often divergent and exhibit poor correlation statis-
tics. Therefore, the patient’s own judgement is
assumed to be the best measure of QOL. That is
why it is designed to use patients as their own
internal control.
Time-variable means that QOL can change over
time. Because of its fluctuating nature meticulous
follow-up and careful attention to the timing of
measurement along the treatment becomes im-
portant.
Subjective means that QOL measures must be
based on the assumption that the ultimate observer
is the involved patient, and that QOL is based on
the patient’s perceptions. QOL implies values based
on subjective functioning in comparison with
personal expectations and is defined by subjective
experiences states and perceptions. By its very
nature it is idiosyncratic to the individual. One of
its characteristics is the incorporation of values and
judgements according to individual preferences.
QOL scores
QOL can be expressed in global scores, summary
scores or as a scatter. Global scores refer to the
scores of a global measure, or a response to
questions such as ‘‘how would you rate your overall
QOL?’’. Summary scores mean that multiple dimen-
sions are grouped and summed in one score. This
kind of summary measures may obscure changes in
different domains, especially if changes in different
domains occur in different directions. A scatter or
the use of one score for each dimension is one
solution and we can compare the form of the plot
to compare the evolution of the patient in long-
itudinal studies or compare the scatter of the
patient with the one from the reference group.
Because QOL is multifactorial it is assumed that
the result can be expressed more adequately as a
scatter instead of a single number. The SF-36
questionnaire produces only a scatter, while the
WHOQOL-Bref questionnaire produces a scatter and
a summary score.38
Metric characteristics of HRQOL
measures
There is no single instrument that can be used to
evaluate outcomes and generate claims across
all HRQOL domains, populations, diseases and
treatments.28
To measure QOL or HRQOL we need appropriate
and accurate measures. These characteristics are a
function of the respondent, the instrument used to
measure, and the objectives of the measurement.
There is no magic bullet instrument. A good
instrument is always dependent on a good choice
by the researcher. Once the domains of interest are
identified we need to choose an instrument that
covers those domains.
The number of instruments developed to mea-
sure HRQOL is enormous. Thus, we need to choose
the ones that fit our objectives best. To do so we
need to consider the seriousness of the studies
published on the instrument and the seriousness of
the organisations that published them, namely the
metric properties. We must consider profit organi-
sations and scientific organisations. Some times
they do not match. Some profit organisations are
very interested in the economic stream and not in
the scientific quality of the instruments. In the field
of HRQOL, we have some good organisations.
QOL measures can be used as an outcome
measure or as a clinical tool. The objective of the
assessment influences the type of measure. When
we discuss measures of this type we can consider
two types of metric properties: psychometric
properties and clinimetric properties.39 The choice
of the metric properties depends on the objective
of the evaluation.
When we choose to use a HRQOL instrument we
are interested in producing a measurement. There-
fore, we need to consider the metric properties
that guarantee the quality of the scores. Selection
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of QOL or HRQOL instruments must consider some
metric properties, namely: validity, i.e. the guar-
antee that the instrument measures the construct
it is supposed to measure. It is possible that an
instrument consistently measures a construct other
than the intended one, making it reliable but not
valid. We must consider three types of validity:
construct, content, and criterion-related.
Reliability is the consistency with which an
instrument measures a given construct, or the
property that guarantees that the instrument
produces the same score if used by a different
person or in different moments. Evidence of this
property can be given through internal consistency
or test–retest. Because QOL varies with time, when
we use test–retest techniques we need to consider
the time gap. Longer gaps mean lower correlation
between the two measures.
Responsiveness is the extent to which a measure
reflects accurately changes in patients’ conditions
due to disease progression or in the expected
direction as consequence of effective treatment.
Clinical significance expresses meaningful
changes in HRQOL. Sometimes differences in
clinical trials can be statistically significant but
not important in a clinical sense (e.g. if a drug
reduced the mean systolic blood pressure from 24
to 20, that can be statistically significant but it is
not clinically significant). The definition of clinical
significance must be defined a priori.
QOL history
Historically, we can consider the Karnofsky perfor-
mance status (KPS)40 as one of the first QOL
measurement scales. It is a measure based on
providers observations of patient functions. Recent
instruments reflect the increasing regard of pa-
tients’ perspectives.
We can find many QOL or HRQOL measures. They
can be general (SF-36) and in that way they are
applicable to any patient regardless of the prevail-
ing medical condition, or they can be specific for a
certain disease (QLQ-C30).
Some international organisations propose QOL
measures for international studies. As an example
we can consider The EORTC cited above. It is a non-
profit organisation founded in 1962 to provide
guidelines for cancer treatment and developed
QOL measures (QLQ-C30) for cancer patients. QLQ-
C30 is a multidimensional questionnaire with 30
items that measure physical functioning, role
functioning, emotional functioning, cognitive func-
tioning, social functioning and health status/QOL.36
These are multi-items scales. The QLQ-C30 also
includes items to measure fatigue, nausea and
vomiting, pain, dyspnoea, insomnia, appetite loss,
constipation, diarrhoea, and financial difficulties.
This is a specific measure for cancer patients but it
is also a generic measure as it can be used in all
types of cancer. The QLQ-C30 also provides specific
modules to add to the generic 30 items. These
modules are specific for certain type of cancer.36
How to use QOL measures
Researchers use QOL measures to evaluate differ-
ent outcomes. Two such outcomes are the QALY and
Q-TWIST. They are generally considered inside the
field of QOL.
QALY
QALY, acronym of quality-adjusted life year, is a
concept developed by economists, more specifi-
cally by health economists as a response to the
interest of health policy makers in cost–benefit
indicators as aids to good decision making. It is a
utility approach to measuring HRQOL.
QALY has been proposed as a standard outcome
measure for cost-effectiveness analysis but also to
express the benefits of medical care, behavioural
intervention, or preventive programmes in terms of
well-years.41 It uses QOL measures to allocate
limited resources or patient choices among com-
peting health programmes. Cost-effectiveness stu-
dies are now common in evaluation of medical
therapies, surgical procedures and new pharma-
ceutical products. Cost–utility studies need a
common measure of health outcome. A QALY is a
year of full QOL gained.42 In this sense, the cost of
an intervention is related to the number of QALYs.
QALY is expressed on a scale between 0 and 1. One
representing perfect health and zero representing
death. QALY builds the scale by combining changes
in survival and QOL of patients.
Various techniques are used to identify QALYs43
such as standard gamble and time trade-off.
Standard gamble was designed to assess the
amount of risk that the respondent is willing to
accept in order to live in the best health state for a
given amount of time. The time trade-off method
respondent chooses between two options: living in
the assessed health state for a given period or living
in perfect health for a shorter period of time.
The value of health states depends on the personal
judgement. Research shows that trade-offs can be
ARTICLE IN PRESS
Quality of life in clinical settings 127
considered and that the position of patients is not
the same as that of the health-care providers.
Otto et al.44 in a study that attempted to
evaluate the impact of a laryngectomy in 46 post-
laryngectomy patients, found that 80.4% of the
patients would not be willing to trade off expec-
tancy of QOL for voice preservation. But 19.6%
indicated a willingness to trade 2 to 10 years of
their anticipated life expectancy in order to
maintain their laryngeal voice and preoperative
QOL. Forty-six per cent of the health-care provi-
ders perceived that their patients would be willing
to accept a reduced life span in order to preserve
their larynx and QOL.
Tsevat et al.45 in another trade-off study de-
signed to identify the values of 440 hospitalised
elderly patients, submitted to different treatments
found they equated 1 year in their current state of
health with living 9.7 months in excellent health.
Of these patients, 40.8% were unwilling to give up
any time in exchange for a shorter life in excellent
health. And 27.8% were willing to give up at the
most 1 month out of 12; 6% were willing to live 2
weeks or less in excellent health rather than 1 year
in their current state of health. Their surrogates
underestimated the patients time trade-off, and
the correlation between patients and their surro-
gates health values was modest ðr ¼ 0:36Þ:
These studies point out that the majority of
patients are unwilling to exchange years of life for
better health. However, a significant number of
patients are willing to exchange many years of life
for better QOL and health-care providers, surro-
gates, and patients have different points of view
about the time trade-off.
Q-TWiST
Q-TWiST is the acronym of time without symptoms
of treatment. It was developed in the field of
oncology and is a crude cost–benefit formula
instead of a QOL indicator. The objective is to
determine the amount of good time that adjuvant
therapy adds to no treatment. The overall survival
time is divided into time with experience of
toxicity, time without symptoms and toxicity, and
time after systemic relapse. It represents a major
attempt to include QOL issues in the decision-
making process in clinical trials.
Size of the questionnaires
In general, QOL questionnaires are small in number
of items. For some patients (like the elderly,
critically ill, or illiterate) more than 10min
answering the questionnaires is too much. For that
reason, questionnaires tend to be short in size and
in time needed to answer. Number of items used in
the questionnaires can vary from one to more than
50. The shorter questionnaires prevail, however,
they depend on the objective of the study and the
conditions of the patients.
International comparisons
It is becoming normal to study people from different
countries, cultures, and languages. To do that, it is
necessary to design the questionnaires in different
languages. The methodology to translate question-
naires is complex. To consider the same question-
naire in different languages or culture as identical is
just an assumption that is probably not true. We
need to consider different equivalencies, such as
item-translation equivalence, operational equiva-
lence, scale equivalence, and metric equivalence.
It is very difficult to meet these standards. This kind
of instrument is based on language and language
means different things in different cultures. We
cannot assume that a questionnaire in Japanese, or
in French, or in Portuguese, means exactly the same
as the original version in English. This has been
discussed in the literature.46,47
Limitations of QOL evaluation
One important question remains: Do we evaluate
QOL or what influences it?
Since the 1990s, some authors have discussed
these issues. For Shumaker et al.,48 QOL ‘‘has been
conceptualised in a variety of ways and there is
disagreement regarding what constitutes quality of
life versus what influences it’’.
For Leventhal and Colman,34 ‘‘the focus on
outcome assessment has led to an overly inclusive
definition of quality of life and to the development
of scales that do not distinguish between the
possible determinants of quality of life and the
quality of life per se’’.
QOL evaluation is yet in its early stages. Further
collaborative studies are required to develop a
better international convergence in the definition
and assessment of QOL.
Where to find a good list of QOL
instruments
We can find free access to synthesised QOL
instruments at a new databaseo www.qolid.org4.
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QOLID is the acronym of the QOL instruments
database.
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